Linical is a global Contract Research Organisation (CRO) dedicated to providing a suite of drug development services from early-phase research to large-scale multinational studies. The organisation operates across all major markets including North America, Europe, and Asia-Pacific, and has a proven track record of supporting biopharmaceutical companies through their clinical development journeys. With its strong business ethos and medical expertise, Linical strives to offer clients high-quality services to fulfil their shared mission of delivering new drugs and therapies to patients all over the world. Linical is a trusted partner of biotech and pharmaceutical companies and for its essential services, we have bestowed the company with a Global Excellence Award.
As a Global Excellence Awards winner Linical is features in Q1 issue of Global Health & Pharma (GHP) Magazine. Read the article to learn why Linical has been awarded the title Best International CRO Service Provider 2023 and how our team strives to offer clients high-quality services, guiding biotech and pharmaceutical companies through every stage of their clinical development journey.
This article is taken from Global Health & Pharma magazine, Q1 2024 edition, pages 12-13.
